SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                          -----------------------------


                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) of the
                         SECURITIES EXCHANGE ACT OF 1934
                         ------------------------------



       Date of Report (Date of earliest event reported): December 30, 1998


                     TECHNICAL CHEMICALS AND PRODUCTS, INC.
             (Exact name of registrant as specified in its charter)


          Florida                         0-25406              65-0308922      
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer 
       of incorporation)                                   Identification No.)


     3341 S.W. 15th Street
     Pompano Beach, Florida                                   33069
(Address of principal executive offices)                   (Zip code)


Registrant's telephone number, including area code: 954/979-0400


                                 Not Applicable
          (Former name or former address, if changed since last report)








Item 5.  Other Events

     On December  30,  1998,  a jury  sitting in the  Circuit  Court of the 17th
Judicial  Circuit in and for Broward  County,  Florida  returned a verdict in an
action  styled  Dr.  Joseph  D'Angelo,   Americare  Transtech,  Inc.,  Americare
Biologicals,  Inc.  and  International  Medical  Associates,  Inc. v.  Technical
Chemicals & Products,  Inc., Jack Aronowitz,  Henry Schur,  Analyte Diagnostics,
Inc., John Faro,  Simplex Medical  Systems,  Inc. and Nicholas  Levandoski.  The
lawsuit  relates to saliva  collector  technology for an HIV diagnostic  test in
which the  plaintiffs  alleged,  among  other  things,  claims  for  intentional
interference with the plaintiffs' business relationships and misappropriation of
trade  secrets  against  Technical   Chemicals  &  Products,   Inc.,  a  Florida
corporation (the  "Registrant"),  the Registrant's  Chairman and Chief Executive
Officer,   Jack  Aronowitz,   and  other  unrelated   corporate  and  individual
defendants.

     In its verdict,  the jury found that the Registrant did not  misappropriate
the plaintiffs'  trade secrets but found that Mr. Aronowitz had  misappropriated
such trade  secrets and awarded  only  Americare  Biologicals,  Inc.  damages of
$500,000 against him, individually.  Additionally,  the jury found that both the
Registrant  and Mr.  Aronowitz  intentionally  interfered  with the  plaintiffs'
business  relationships.  The jury  awarded  only  Americare  Biologicals,  Inc.
approximately $328,000 in damages against the Registrant in connection with this
second  claim but awarded no damages  against Mr.  Aronowitz,  individually,  in
connection  with that  claim.  Separately,  the jury  awarded  approximately  $4
million  in  damages  against  the  other  unrelated  corporate  and  individual
defendants.  A judgement was entered by the trial court in  accordance  with the
verdict on January 28, 1999.

     On January 29, 1999 the Registrant filed a Notice of Appeal seeking to have
the verdicts  against both the  Registrant and Mr.  Aronowitz set aside.  In the
event  that  Mr.  Aronowitz  is  ultimately  required  to  pay  damages  to  the
plaintiffs,  the Registrant will indemnify Mr. Aronowitz to the extent permitted
by law. The  Registrant  has  obtained an appeal bond  staying  enforment of the
Judgement  against the  Registrant and Mr.  Aronowitz  until such time as to the
Appellate Court issues its ruling.




                                   SIGNATURES


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


Dated: February 9, 1999               TECHNICAL CHEMICALS & PRODUCTS, INC.



                                      By:/s/              
                                         --------------------------------
                                         Stuart Streger
                                         Vice President, Chief Financial Officer